The Chronic Lymphocytic Leukemia Channel is supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
iwCLL 2019 | Implications of CytoGPS
Kevin Coombes
• 22 Sep 2019
Kevin Coombes, PhD, Ohio State University, Columbus, OH, provides an introduction to cytoGPS and its applications in understanding the disease biology and the genetic basis of chronic lymphocytic leukemia (CLL) at the 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) Biennial Meeting, held in Edinburgh, UK.
